BICX BioCorRx Inc.
Services-Specialty Outpatient Facilities, NEC · OTC · SEC CIK 1443863 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-78.9%
TTM net income YoY51.3%
TTM EPS YoY52.0%
Revenue 3-yr CAGR-10.2%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin-3,921.4%
Net margin-1,837.6%
FCF margin—
EBITDA margin-4,007.3%
Returns
ROE—
ROA-43.8%
ROIC (approx.)—
Asset turnover0.02x
Leverage & solvency
Liabilities / assets826.2%
Debt / equity—
Current ratio0.06x
Interest coverage-30.03x
Cash quality & payout
Operating cash flow / net income0.93x
Accruals ratio-3.0%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2024Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | -$40,348 | $87,970 | $214,539 | -$151,118 | $213,910 | $178,238 | $134,899 | $0 |
| Cost of revenue | $2,625 | $144,967 | $25,184 | — | $0 | $0 | $0 | $0 |
| Gross profit | -$42,973 | -$56,997 | $189,355 | — | $213,910 | $178,238 | $134,899 | $0 |
| R&D expense | $746,064 | $712,384 | $352,333 | $305,516 | $1.00M | $296,860 | $161,919 | $272,543 |
| SG&A expense | $601,248 | $686,323 | $775,453 | $539,366 | $902,594 | $1.22M | $886,083 | $839,193 |
| Operating income | -$1.40M | -$1.47M | -$956,000 | -$534,185 | -$1.77M | -$1.41M | -$937,946 | -$1.12M |
| Interest expense | $37,377 | $37,377 | $31,041 | $39,186 | $60,495 | $36,686 | $87,483 | $128,054 |
| Pretax income | -$810,673 | -$1.00M | -$859,892 | -$471,218 | -$811,332 | -$1.38M | -$851,764 | -$1.23M |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$797,134 | -$964,774 | -$831,227 | $552,555 | -$847,091 | -$1.23M | -$841,407 | -$1.27M |
| EBITDA | -$1.39M | -$1.46M | -$944,805 | -$658,989 | -$1.69M | -$1.34M | -$913,103 | -$1.11M |
| EPS (diluted) | -0.03 | -0.03 | -0.03 | — | -0.05 | -0.07 | -0.06 | — |
| Weighted avg. shares (diluted) | 30.10M | 29.22M | 25.60M | — | 18.56M | 17.01M | 15.09M | — |
| Banking | ||||||||
| Noninterest income | — | — | — | — | — | — | $10,357 | $63,018 |
| Balance sheet | ||||||||
| Cash & equivalents | $18,233 | $21,237 | $211,911 | $139,360 | $287,688 | $111,872 | $24,142 | $88,033 |
| Receivables | $0 | $67,694 | $330,348 | $253,459 | $194,442 | $51,242 | $111,966 | $0 |
| Inventory | $164,118 | $43,551 | $143,425 | $143,425 | $155,367 | $133,597 | $133,597 | $0 |
| Current assets | $528,740 | $623,377 | $1.02M | $814,468 | $1.46M | $527,483 | $565,796 | $117,996 |
| PP&E, net | $0 | $0 | $1,452 | $4,062 | $7,685 | $11,083 | $15,213 | $18,977 |
| Goodwill | $563,158 | $563,158 | $563,158 | $563,158 | $2.84M | $2.84M | $2.84M | $0 |
| Intangibles | $532,645 | $541,119 | $549,501 | $564,460 | $3.01M | $3.08M | $3.15M | $7,848 |
| Total assets | $1.79M | $1.91M | $2.32M | $2.15M | $7.53M | $6.68M | $6.80M | $385,941 |
| Current liabilities | $9.18M | $8.85M | $8.53M | $8.31M | $15.04M | $14.56M | $13.44M | $8.21M |
| Short-term debt | $103,521 | — | — | $0 | — | — | — | — |
| Total liabilities | $14.82M | $14.38M | $13.95M | $13.67M | $20.30M | $19.69M | $18.60M | $12.74M |
| Shareholders' equity | -$12.76M | -$12.22M | -$11.45M | -$11.22M | -$13.48M | -$12.62M | -$11.56M | -$12.12M |
| Shares outstanding | 30.52M | 29.67M | 28.91M | 24.49M | 11.21M | 17.28M | 16.90M | 13.30M |
| Cash flow statement | ||||||||
| Operating cash flow | -$179,615 | -$440,289 | -$432,971 | -$847,722 | -$634,447 | -$126,499 | -$689,623 | -$247,170 |
| Financing cash flow | $176,611 | $249,615 | $505,522 | $699,394 | $810,263 | $214,229 | $625,732 | $335,113 |
| Depreciation & amortization | $8,474 | $9,834 | $11,195 | -$124,804 | $71,987 | $71,977 | $24,843 | $13,004 |
| Stock-based compensation | $0 | $0 | $108,375 | $149,760 | $30,715 | $0 | $151,257 | $285,533 |
Free plan shows the latest 8 periods; Pro shows all 67 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.